Dynamics of fibrotic and vascular endothelial dysfunction markers in elderly hypertensive patients after ischemic stroke receiving beta-blockers
Open Access
- 8 January 2022
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 20 (8), 3087
- https://doi.org/10.15829/1728-8800-2021-3087
Abstract
Aim. To compare the effect of beta-blocker therapy (bisoprolol and nebivolol) on the dynamics of fibrotic and vascular endothelial dysfunction markers in elderly hypertensive patients after ischemic stroke (IS).Material and methods. This prospective cohort study included 75 hypertensive patients who were admitted to the hospital due to IS. The mean age of patients was 67±6 years. The average National Institutes of Health Stroke Scale (NIHSS) score was 7±3. The followup period was 6 months. The control group consisted of 20 elderly people with hypertension without prior myocardial infarction. The patients were divided into groups based on received therapy: group 1 (n=38) — bisoprolol; group 2 (n=37) — nebivolol. The level of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) was determined by enzyme-linked immunosorbent assay (ELISAKit, USA). Vascular ultrasound was carried out using a LOGIQP9 (GE) system according to the Celermajer method.Results. After 6-month nebivolol, we revealed a decrease in the level of MMP-9 by 30,2% (pConclusion. The results obtained indicate that the beta-blocker nebivolol at an average dose of 8,55+1,75 mg/day significantly reduces the vascular fibrosis, normalizes the ratio of collagen synthesis and degradation markers, improves the vasodilation brachial artery properties in comparison with bisoprolol in elderly hypertensive patients after IS.Keywords
This publication has 23 references indexed in Scilit:
- Comparative efficacy of β-blockers on mortality and cardiovascular outcomes in patients with hypertension: a systematic review and network meta-analysisJournal of the American Society of Hypertension, 2017
- The Role of Matrix Metalloproteinase Polymorphisms in Ischemic StrokeInternational Journal of Molecular Sciences, 2016
- Effect of β-Adrenergic Antagonists on In-Hospital Mortality after Ischemic StrokeJournal of Stroke and Cerebrovascular Diseases, 2015
- Endothelial dysfunction : the early predictor of atherosclerosisCardioVascular Journal of Africa, 2012
- Matrix Metalloproteinase-9 as a Marker for Acute Ischemic Stroke: A Systematic ReviewJournal of Stroke and Cerebrovascular Diseases, 2011
- Structure and function of matrix metalloproteinases and TIMPsCardiovascular Research, 2006
- Dual Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and Atherosclerotic Plaque RupturePhysiological Reviews, 2005
- Identification of 92-kD Gelatinase in Human Coronary Atherosclerotic LesionsCirculation, 1995
- Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisThe Lancet, 1992
- Interrater Reliability of the NIH Stroke ScaleArchives of Neurology, 1989